GeneTex, Inc started operations in early 1997, founded by 3 internationally known scientists with recognised expertise in oncology and infectious diseases. The initial focus was on a portfolio of reagents that met the needs of researchers working to find out what causes cancer, how it can be better diagnosed and related studies. They have since added tools for scientists studying basic mechanism common to many forms of cancer; tools such as immunological reagents used to study specific proteins and events involved in the regulation of the cell cycle and DNA repair and replication.

Country of Origin:  USA